In clinical trials, uninterrupted access to properly calibrated instruments is essential—regulators and good practice standards generally require recalibration at least every 12 months—yet sending devices away for routine recalibration can leave sites without vital equipment and disrupt study operations.
LABFISH’s reCAL Exchange Program solves this problem by proactively tracking each instrument’s calibration expiry, contacting sites ahead of time, and delivering a freshly calibrated replacement. Hence, the site never goes without a working, in-spec device.
When the new instrument arrives, we collect the outgoing unit for recalibration and re-stocking, creating a smooth, single-point logistics flow that eliminates site downtime and the administrative hassle of arranging returns, shipping, and temporary replacements.
The operational and compliance benefits are immediate and measurable. Continuous instrument availability reduces the risk of missed measurements, protocol deviations, and delayed enrollments.
Centralized scheduling and lot-level certificate management strengthen the audit trail and simplify inspections. Predictable, repeatable exchanges lower the administrative burden on site staff, allowing them to focus on patient care. Because replacements arrive fully documented and calibrated to traceable standards, sponsors gain confidence in data integrity and traceability across sites.
In short, the reCAL Exchange Program delivers seamless uptime, robust regulatory documentation, and a cost-effective, scalable way to keep every study site equipped with validated, inspection-ready instruments at all times.